본문 바로가기
KERD
논문KCI 등재

Drug-herb interactions: Mechanisms involved and clinical implications of five commonly and traditionally used herbs

Chin Eng Ong|Yan Pan
셀메드 세포교정의약학회 (Cellmed Orthocellular Medicine and Pharmaceutical Association)|2014.08|셀메드 (CELLMED)|제4권 제3호|pp. 17-17|DOI http://dx.doi.org/10.5667/tang.2014.0008

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

cytochrome P450pharmacokineticspharmacodynamicsP-glycoproteindrug-herb interaction
주제분류의학일반

초록

Herbal remedies are commonly used by patients worldwide. Because these herbal preparations share the same metabolic and transport proteins with prescribed medicines, the potential for a drug-herb interaction is substantial and is an issue of significant concern. This review paper summarizes drug-herb interactions involving inhibition or induction of cytochrome P450 enzymes, drug transporters as well as modulation of drug pharmacodynamics. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and implications of these studies are discussed in this review. The most commonly implicated drugs in the interaction include anticoagulants, antiplatelets, immunosuppressants, anti-neoplastics, protease inhibitors, and some antidepressants. Pharmacokinetic and/or pharmacodynamic interactions of five commonly used herbal remedies (danshen, garlic, Ginkgo biloba, ginseng, and St John’s wort) with these drugs are presented, with focus of discussion being the potentials for interaction, their mechanisms and clinical implications. There is a necessity for adequate pharmacovigilance to be carried out in minimizing unanticipated but often preventable drug-herb interactions.

Abstract

Herbal remedies are commonly used by patients worldwide. Because these herbal preparations share the same metabolic and transport proteins with prescribed medicines, the potential for a drug-herb interaction is substantial and is an issue of significant concern. This review paper summarizes drug-herb interactions involving inhibition or induction of cytochrome P450 enzymes, drug transporters as well as modulation of drug pharmacodynamics. An increasing number of in vitro and animal studies, case reports and clinical trials evaluating such interactions have been reported, and implications of these studies are discussed in this review. The most commonly implicated drugs in the interaction include anticoagulants, antiplatelets, immunosuppressants, anti-neoplastics, protease inhibitors, and some antidepressants. Pharmacokinetic and/or pharmacodynamic interactions of five commonly used herbal remedies (danshen, garlic, Ginkgo biloba, ginseng, and St John’s wort) with these drugs are presented, with focus of discussion being the potentials for interaction, their mechanisms and clinical implications. There is a necessity for adequate pharmacovigilance to be carried out in minimizing unanticipated but often preventable drug-herb interactions.

참고문헌 (73)

  1. Aruna D, "Pharmacodynamic interaction studies of Ginkgo biloba with cilostazol and clopidogrel in healthy human subjects", Br J Clin Pharmacol, 63, pp.333~338 (2006)
  2. Attele AS, "Ginseng pharmacology : multiple constituents and multiple actions", Biochem Pharmacol, 58, pp.1685~1693 (1999)
  3. Bauer S, "Alterations in cyclosporinA pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients", Br J Clin Pharmacol, 55, pp.203~211 (2003)
  4. Becker BN, "Ginseng-induced diuretic resistance", JAMA, 276, pp.606~607 (1996)
  5. Beckert BW, "The effect of herbal medicines on platelet function : an in vivo experiment and review of the literature", Plast Reconstr Surg, 120, pp.2044~2050 (2007)
  6. Black DJ, "Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies", Drug Metab Dispos, 24, pp.422~428 (1996)
  7. Block E, "The chemistry of garlic and onions", Sci Am, 252, pp.114~119 (1985)
  8. Bone KM, "Potential interaction of Ginkgo biloba leaf with antiplatelet or anticoagulant drugs: what is the evidence?", Mol Nutr Food Res, 52, pp.764~771 (2008)
  9. Bonetto N, "Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and Hypericum", Cephalalgia, 27, pp.1421~1423 (2007)
  10. Borrelli F, "Garlic (Allium sativum L.): adverse effects and drug interactions in humans", Mol Nutr Food Res, 51, pp.1386~1397 (2007)
  11. Boruban MC, "Tamoxifen inhibits cytochrome P450 2C9 activity in breastcancer patients", J Chemother, 18, pp.421~424 (2006)
  12. Butterweck V, "St John's wort : role of active compounds for its mechanism of action and efficacy", Wien Med Wochenschr, 157, pp.356~361 (2007)
  13. Chan K, "The effects of Danshen(Salvia miltiorrhiza)on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats", J Pharm Pharmacol, 47, pp.402~406 (1995)
  14. Chang TK, "In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1", Drug Metab Dispos, 30, pp.378~384 (2002)
  15. Cheng TO, "Cardiovascular effects of Danshen", Int J Cardiol, 121, pp.9~22 (2007)
  16. Cox MC, "Influence of garlic(Allium sativum)on the pharmacokinetics of docetaxel", Clin Cancer Res, 12, pp.4636~4640 (2006)
  17. Dannawi M, "Possible serotonin syndrome after combination of buspirone and St John's wort", J Psychopharmacol, 16, pp.401~ (2002)
  18. DeFeudis FV, "Ginkgo biloba extract(EGb 761)and CNS functions : basic studies and clinical applications", Curr Drug Targets, 1, pp.25~58 (2000)
  19. deMaat MM, "Drug interaction between St John's wort and nevirapine", AIDS, 15, pp.420~421 (2001)
  20. Deng JF, "Clinical and laboratory investigations in herbal poisonings", Toxicology, 181-182, pp.571~576 (2002)
  21. Dresser GK, "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition", Clin Pharmacokinet, 38, pp.41~57 (2000)
  22. Foster BC, "Effect of several Chinese natural health products of human cytochrome P450 metabolism", J Pharm Pharm Sci, 5, pp.185~189 (2002)
  23. Gallicano K, "Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers", Br J Clin Pharmacol, 55, pp.199~202 (2003)
  24. Gao S, "Cardiovascular actions and therapeutic potential of tanshinone IIA", Atherosclerosis, 220, pp.3~10 (2012)
  25. Greenblatt DJ, "Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate", J Clin Pharmacol, 46, pp.214~221 (2006)
  26. Gurley BJ, "Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans", Clin Pharmacol Ther, 72, pp.276~287 (2002)
  27. Gurley BJ, "Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly : St John's wort, garlic oil, Panax ginseng and Ginkgo biloba", Drugs Aging, 22, pp.525~539 (2005)
  28. Hafner V, "Effect of simultaneous induction andinhibition of CYP3A by St John's wort and ritonavir on CYP3A activity", Clin Pharmacol Ther, 87, pp.191~196 (2010)
  29. He N, "Effects of individual ginsenosides, ginkgolides and flavonoids on CYP2C19 and CYP2D6 activity in human liver microsomes", Clin Exp Pharmacol Physiol, 33, pp.813~815 (2006)
  30. Hebert MF, "Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers", J Clin Pharmacol, 44, pp.89~94 (2004)
  31. Izzat MB, "A taste of Chinese medicine!", Ann Thorac Surg, 66, pp.941~942 (1998)
  32. Izzo AA, "Herbal medicine : the dangers of drug interaction", Trends Pharmacol Sci, 23, pp.358~391 (2002)
  33. Janetzky K, "Probable interaction between warfarin and ginseng", Am J Heath Syst Pharm, 54, pp.692~693 (1997)
  34. Kauffman DW, "Recent patterns of medication use in the ambulatory adult population of the United States", JAMA, 287, pp.337~344 (2002)
  35. Klotz U, "Pharmacokinetics and drug metabolism in the elderly", Drug Metab Rev, 41, pp.67~76 (2009)
  36. Kremers P, "In vitro tests for predicting drug-drug interactions : the need for validated procedures", Pharmacol Toxicol, 91, pp.209~217 (2002)
  37. Kuo SC, "Antiplatelet components in Panax ginseng", Planta Med, 56, pp.164~167 (1990)
  38. Kuo YH, "Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza", J Pharm Pharmacol, 58, pp.521~527 (2006)
  39. Lam FF, "Pharmacological evidence for calcium channel inhibition by Danshen(Salvia miltiorrhiza)on rat isolated femoral artery", J Cardiovasc Pharmacol, 47, pp.139~145 (2006)
  40. Lei HP, "Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers", Br J Clin Pharmacol, 68, pp.201~206 (2009)
  41. Linde K, "St. John's wort for major depression", Cochrane Database Syst Rev, pp.CD000448~ (2008)
  42. Lo AC, "The effects of Danshen(Salvia miltiorrhiza)on pharmacokinetics and pharmacodynamics of warfarin in rats", Eur J Drug Metab Pharmacokinet, 17, pp.257~262 (1992)
  43. Mai I, "Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction", Clin Pharmacol Ther, 76, pp.330~340 (2004)
  44. Mai I, "Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients", Nephrol Dial Transplant, 18, pp.819~822 (2003)
  45. Markowitz JS, "Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers", J Clin Psychopharmacol, 23, pp.576~581 (2003)
  46. Mathhews MK Jr, "Association of ginkgo biloba with intracerebral haemorrhage", Neurology, 50, pp.1933~1934 (1998)
  47. Mohutsky MA, "Ginkgo biloba : evaluation of CYP2C9 drug interactions in vitro and in vivo", Am J Ther, 13, pp.24~31 (2006)
  48. Morris J, "Effects of garlic extract on platelet aggregation : a randomized placebo-controlled double-blind study", Clin Exp Pharmacol Physiol, 22, pp.414~417 (1995)
  49. Mullins ME, "Life-threatening interaction of mibefradil and b-blockers with dihydropyridine calcium channel blockers", JAMA, 280, pp.157~158 (1998)
  50. Palmer ME, "Adverse events associated with dietary supplements : an observational study", Lancet, 361, pp.101~106 (2003)
  51. Pathak A, "Garlic interaction with fluindione : a case report", Therapie, 58, pp.380~381 (2003)
  52. Piscitelli SC, "Indinavir concentrations and St John's wort", Lancet, 355, pp.547~548 (2000)
  53. Piscitelli SC, "The effect of garlic supplements on the pharmacokinetics of saquinavir", Clin Infect Dis, 34, pp.234~238 (2002)
  54. Qi LW, "Isolation and analysis of ginseng : advances and challenges", Nat Prod Rep, 28, pp.467~495 (2011)
  55. Qiu F, "Effect of danshen extract on pharmacokinetics of theophylline in healthy volunteers", Br J Clin Pharmacol, 65, pp.270~274 (2008)
  56. Robertson SM, "Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects", Curr Med Res Opin, 24, pp.591~599 (2008)
  57. Rosado MF, "Thrombosis of a prosthetic aortic valve disclosing a hazardous interaction between warfarin and a commercial ginseng product", Cardiology, 99, pp.111~ (2003)
  58. Rossenblatt M, "Spontaneous hyphema associated with ingestion of Ginkgo biloba extract", N Engl J Med, 336, pp.1108~ (1997)
  59. Shi S, "Drug interactions with herbal medicines", Clin Pharmacokinet, 51, pp.77~104 (2012)
  60. Singh YP, "In silico studies of organosulfur-functional active compounds in garlic", Biofactors, 36, pp.297~311 (2010)
  61. Smith M, "An open trial of nifedipine-herb interactions: nifedipine with St John's wort, ginseng or ginkgo biloba", Clin Pharmacol Ther, 69, pp.P89~ (2001)
  62. Solecki RS, "A Neanderthal flower burial in northern Iraq", Science, 190, pp.880~881 (1975)
  63. Solomon D, "Potential of St John's wort for the treatment of depression : the economic perspective", Aust N Z J Psychiatry, 45, pp.123~130 (2011)
  64. Vaes LP, "Interactions of warfarin with garlic, ginger, ginkgo, or ginseng : nature of the evidence", Ann Pharmacother, 34, pp.1478~1482 (2000)
  65. Ueng YF, "Induction of CYP1A by a diterpene quinine tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL", 6J but not in DBA, Life Sci, pp.2004, 74[DOI]
  66. van Beek TA, "Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals", J Chromatogr A, 1216, pp.2002~2032 (2009)
  67. Vlachojannis J, "Drug interactions with St John's wort products", Pharmacol Res, 63, pp.254~256 (2011)
  68. Weinmann S, "Effects of Ginkgo biloba in dementia : systematic review and meta-analysis", BMC Geriatr, 10, pp.14~ (2010)
  69. Yin OQ, "Pharmacogenetics and herb-drug interactions : experience with Ginkgo biloba and omeprazole", Pharmacogenetics, 14, pp.841~850 (2004)
  70. Yoshioka M, "Studies on interactions between functional foods or dietary supplements and medicines: IV. Effects of Ginkgo biloba leaf extract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers", Biol Pharm Bull, 27, pp.2006~2009 (2004)
  71. Yu CM, "Chinese herbs and warfarin potentiation by 'danshen'", J Intern Med, 241, pp.337~339 (1997)
  72. Yu CT, "Lack of evidence for induction of CYP2B1, CYP3A23, and CYP1A2 gene expression by Panax ginseng and Panax quinquefolius extracts in adult rats and primary cultures of rat hepatocytes", Drug Metab Dispos, 33, pp.19~22 (2005)
  73. Zhou S, "Herbal bioactivation : the good, the bad and the ugly", Life Sci, 74, pp.935~968 (2004)

관련 논문AI추천

와파린과 생약제의 약물 상호작용 리뷰구본기, 김정태, 김종윤, 유기연, 천부순한국병원약사회 · 병원약사회지2013 · 제30권 제5호항혈소판약물과 생약제의 상호작용: 리뷰김정태, 김종윤, 유기연, 천부순한국병원약사회 · 병원약사회지2014 · 제31권 제2호와파린과 상호작용하는 한약재에 대한 고찰이인, 권정남, 김도형, 박상무, 박승찬, 조민경, 한창우, 홍진우대한한방내과학회 · 대한한방내과학회지2012 · 제33권 제2호한약의 약물상호작용 기전과 연구방향- 독성학적인 측면을 중심으로 -김명동, 박영철, 이선동대한예방한의학회 · 대한예방한의학회지2011 · 제15권 제1호생약제제의 약물동태 연구 및 상호작용강원구, 김은정, 노금한, 윤영란, 이혜원, 임미선, 정원필한국임상약학회 · 한국임상약학회지2010 · 제20권 제2호국내 한약-양약 상호작용 연구논문 분석을 통한 상호작용 정보 현황파악 및 제공방안에 대한 연구권영규, 박수진, 신재국한의병리학회 · 동의생리병리학회지2010 · 제24권 제4호

이 간행물의 다른 논문 (6건)

Andrographolides and traditionally used Andrographis paniculata as potential adaptogens: Implications for therapeutic innovationShyam Sunder Chatterjee, Ajit Kumar Thakur, Vikas Kumarpp. 15-15Traditional oil palm (Elaeis guineensis jacq.) and its medicinal uses: A reviewGbenga Opeyemi Owolabi, Bamidele Victor Owoyelepp. 16-16Hepatoprotective and antioxidant activity of Leea asiatica leaves against acetaminophen-induced hepatotoxicity in ratsSaikat Sen, N Devanna, Raja Chakraborty, Biplab Depp. 18-18Traditional Unani perspective of perceived insufficient milk (Qillatul Laban) and Galactogogues: A literary research with recent studiesKhaleequr Rahman, Arshiya Sultanapp. 19-19Effect of an extract of Bauhinia variegata leaves on chronic arsenic intoxication in mice (Mus musculus): A preliminary studySurjyo Jyoti Biswas, Goutam Ghoshpp. 20-20
원문 보기